124 related articles for article (PubMed ID: 1328923)
61. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells.
Ingi T; Kitajima Y; Minamitake Y; Nakanishi S
J Pharmacol Exp Ther; 1991 Dec; 259(3):968-75. PubMed ID: 1662278
[TBL] [Abstract][Full Text] [Related]
62. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
63. Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptors.
Conlon JM; Warner FJ; Burcher E
J Pept Res; 1998 Mar; 51(3):210-5. PubMed ID: 9531424
[TBL] [Abstract][Full Text] [Related]
64. Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder.
Patacchini R; Giuliani S; Turini A; Navarra G; Maggi CA
Eur J Pharmacol; 2000 Jun; 398(3):389-97. PubMed ID: 10862829
[TBL] [Abstract][Full Text] [Related]
65. Receptor binding profile of neuropeptide gamma and its fragments: comparison with the nonmammalian peptides carassin and ranakinin at three mammalian tachykinin receptors.
Badgery-Parker T; Lovas S; Conlon JM; Burcher E
Peptides; 1993; 14(4):771-5. PubMed ID: 8234024
[TBL] [Abstract][Full Text] [Related]
66. Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonists.
Quartara L; Fabbri G; Ricci R; Patacchini R; Pestellini V; Maggi CA; Pavone V; Giachetti A; Arcamone F
J Med Chem; 1994 Oct; 37(21):3630-8. PubMed ID: 7932590
[TBL] [Abstract][Full Text] [Related]
67. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
68. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor.
Buck SH; Burcher E; Shults CW; Lovenberg W; O'Donohue TL
Science; 1984 Nov; 226(4677):987-9. PubMed ID: 6095447
[TBL] [Abstract][Full Text] [Related]
69. Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists.
Deal MJ; Hagan RM; Ireland SJ; Jordan CC; McElroy AB; Porter B; Ross BC; Stephens-Smith M; Ward P
J Med Chem; 1992 Oct; 35(22):4195-204. PubMed ID: 1331460
[TBL] [Abstract][Full Text] [Related]
70. The presence of NK3 tachykinin receptors on rat uterus.
Barr AJ; Watson SP; Bernal AL; Nimmo AJ
Eur J Pharmacol; 1991 Oct; 203(2):287-90. PubMed ID: 1724757
[TBL] [Abstract][Full Text] [Related]
71. Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells.
van Giersbergen PL; Shatzer SA; Henderson AK; Lai J; Nakanishi S; Yamamura HI; Buck SH
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1661-5. PubMed ID: 1848006
[TBL] [Abstract][Full Text] [Related]
72. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.
Giuliani S; Barbanti G; Turini D; Quartara L; Rovero P; Giachetti A; Maggi CA
Eur J Pharmacol; 1991 Oct; 203(3):365-70. PubMed ID: 1723045
[TBL] [Abstract][Full Text] [Related]
73. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
74. Receptors for neurokinins, tachykinins, and bombesin: a pharmacological study.
Regoli D; Dion S; Rhaleb NE; Drapeau G; Rouissi N; D'Orléans-Juste P
Ann N Y Acad Sci; 1988; 547():158-73. PubMed ID: 2853591
[No Abstract] [Full Text] [Related]
75. An investigation of tachykinin NK2 receptor subtypes in the rat.
Matuszek MA; Zeng XP; Strigas J; Burcher E
Eur J Pharmacol; 1998 Jul; 352(1):103-9. PubMed ID: 9718274
[TBL] [Abstract][Full Text] [Related]
76. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
77. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
Ellis JL; Undem BJ; Kays JS; Ghanekar SV; Barthlow HG; Buckner CK
J Pharmacol Exp Ther; 1993 Oct; 267(1):95-101. PubMed ID: 8229792
[TBL] [Abstract][Full Text] [Related]
78. Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Lippi A; Guelfi M; Quartara L; Maggi CA
Biochem Biophys Res Commun; 1998 Jul; 248(1):78-82. PubMed ID: 9675089
[TBL] [Abstract][Full Text] [Related]
79. Functional nonequivalence of structurally homologous domains of neurokinin-1 and neurokinin-2 type tachykinin receptors.
Blount P; Krause JE
J Biol Chem; 1993 Aug; 268(22):16388-95. PubMed ID: 8393861
[TBL] [Abstract][Full Text] [Related]
80. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
